Glass Jacobson Investment Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29K	Hold	2,000	–	–	0.01%	385
2026 Q1	$27.7K	Hold	2,000	–	–	0.01%	379
2025 Q4	$28.1K	Hold	2,000	–	–	0.01%	372
2025 Q3	$28K	Hold	2,000	–	–	0.01%	362
2025 Q2	$30.1K	Hold	2,000	–	–	0.01%	342
2025 Q1	$31.6K	Hold	2,000	–	–	0.01%	440
2024 Q4	$31.6K	Hold	2,000	–	–	0.01%	440
2024 Q3	$31.8K	Hold	2,000	–	–	0.01%	434
2024 Q2	$30.5K	Hold	2,000	–	–	0.01%	415
2024 Q1	$29.3K	Hold	2,000	–	–	0.01%	433
2023 Q4	$27.8K	Hold	2,000	–	–	0.01%	410
2023 Q3	$26.7K	Hold	2,000	–	–	0.01%	391
2023 Q2	$25.2K	Buy	+2,000	New	+$23.3K	0.01%	408
2022 Q4	$20.7K	Buy	+2,000	New	+$21.6K	0.01%	425

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

FRA

Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Glass Jacobson Investment Advisors's RDY Position: Q2 2026 in Review

Glass Jacobson Investment Advisors held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 2,000 shares worth $29K. The position accounts for 0.01% of the portfolio, ranked #385.

Glass Jacobson Investment Advisors first reported a position in RDY in Q4 2022 and has held it in 14 quarters since. The position peaked at $31.8K in Q3 2024. 63 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Glass Jacobson Investment Advisors held 2,000 shares of Dr. Reddy's Laboratories worth $29K as of Q2 2026.
Glass Jacobson Investment Advisors left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up 0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #385 holding.
Glass Jacobson Investment Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2022 and has held it in 14 quarters since.
Glass Jacobson Investment Advisors's Dr. Reddy's Laboratories position peaked at $31.8K in Q3 2024.
63 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.